Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study.

Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP.

J Am Coll Cardiol. 2012 Feb 14;59(7):673-80. doi: 10.1016/j.jacc.2011.11.012.

2.

Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).

Azarbal F, Welles CC, Wong JM, Whooley MA, Schiller NB, Turakhia MP.

Am J Cardiol. 2014 Apr 1;113(7):1166-72. doi: 10.1016/j.amjcard.2013.12.028. Epub 2014 Jan 15.

PMID:
24507169
3.

Left atrial expansion index predicts all-cause mortality and heart failure admissions in dyspnoea.

Hsiao SH, Chiou KR.

Eur J Heart Fail. 2013 Nov;15(11):1245-52. doi: 10.1093/eurjhf/hft087. Epub 2013 May 22.

4.

Relation of left atrial dysfunction to ischemic stroke in patients with coronary heart disease (from the heart and soul study).

Wong JM, Welles CC, Azarbal F, Whooley MA, Schiller NB, Turakhia MP.

Am J Cardiol. 2014 May 15;113(10):1679-84. doi: 10.1016/j.amjcard.2014.02.021. Epub 2014 Mar 3.

PMID:
24792737
5.

Left atrial function index predicts long-term survival in stable outpatients with systolic heart failure.

Sargento L, Vicente Simões A, Longo S, Lousada N, Palma Dos Reis R.

Eur Heart J Cardiovasc Imaging. 2017 Feb;18(2):119-127. doi: 10.1093/ehjci/jew196. Epub 2016 Sep 27.

PMID:
27679598
6.

Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.

Santos AB, Roca GQ, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Fang JC, Zile MR, Pitt B, Solomon SD, Shah AM.

Circ Heart Fail. 2016 Apr;9(4):e002763. doi: 10.1161/CIRCHEARTFAILURE.115.002763.

7.

Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.

Pellicori P, Zhang J, Lukaschuk E, Joseph AC, Bourantas CV, Loh H, Bragadeesh T, Clark AL, Cleland JG.

Eur Heart J. 2015 Mar 21;36(12):733-42. doi: 10.1093/eurheartj/ehu405. Epub 2014 Oct 21.

PMID:
25336215
8.

Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.

Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD; PARAMOUNT Investigators.

J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30. Erratum in: J Am Coll Cardiol. 2014 Jul 22;64(3):335.

9.

Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.

Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA.

Circ Heart Fail. 2015 Mar;8(2):295-303. doi: 10.1161/CIRCHEARTFAILURE.114.001667. Epub 2015 Jan 15.

10.

Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure.

Ky B, French B, May Khan A, Plappert T, Wang A, Chirinos JA, Fang JC, Sweitzer NK, Borlaug BA, Kass DA, St John Sutton M, Cappola TP.

J Am Coll Cardiol. 2013 Sep 24;62(13):1165-72. doi: 10.1016/j.jacc.2013.03.085. Epub 2013 Jun 13.

11.

Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction.

Sanchis L, Gabrielli L, Andrea R, Falces C, Duchateau N, Perez-Villa F, Bijnens B, Sitges M.

Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):62-7. doi: 10.1093/ehjci/jeu165. Epub 2014 Sep 3.

PMID:
25187609
13.

Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.

Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH, Lakatta EG, Najjar SS, Kass DA.

J Am Coll Cardiol. 2007 Jan 16;49(2):198-207. Epub 2006 Dec 29.

14.

Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women.

Hung CL, Hung TC, Liu CC, Wu YJ, Kuo JY, Hou CJ, Yeh HI.

Am J Cardiol. 2012 Oct 1;110(7):993-1000. doi: 10.1016/j.amjcard.2012.05.030. Epub 2012 Jun 22.

PMID:
22728006
15.

Left Atrial Expansion Index Predicts Left Ventricular Filling Pressure and Adverse Events in Acute Heart Failure With Severe Left Ventricular Dysfunction.

Hsiao SH, Chu KA, Wu CJ, Chiou KR.

J Card Fail. 2016 Apr;22(4):272-9. doi: 10.1016/j.cardfail.2016.01.009. Epub 2016 Jan 19.

PMID:
26805452
16.

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).

Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ.

Circulation. 2017 Feb 21;135(8):724-735. doi: 10.1161/CIRCULATIONAHA.116.024593. Epub 2017 Jan 4.

PMID:
28052977
17.

Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.

Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, Ohba K, Matsubara J, Maeda H, Horibata Y, Sakamoto K, Sugamura K, Yamamuro M, Sumida H, Kaikita K, Iwashita S, Matsui K, Kimura K, Umemura S, Ogawa H.

J Am Coll Cardiol. 2012 Oct 30;60(18):1778-86. doi: 10.1016/j.jacc.2012.07.036. Epub 2012 Oct 3.

18.

[Chronic heart failure].

Hradec J.

Cas Lek Cesk. 2015;154(6):260-8. Czech.

PMID:
26750621
19.

Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study).

Smith DT, Farzaneh-Far R, Ali S, Na B, Whooley MA, Schiller NB.

Am J Cardiol. 2010 Jan 15;105(2):223-8. doi: 10.1016/j.amjcard.2009.08.677.

20.

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B.

JACC Heart Fail. 2015 Jun;3(6):429-441. doi: 10.1016/j.jchf.2014.12.017. Epub 2015 May 14.

PMID:
25982110

Supplemental Content

Support Center